HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study.

AbstractBACKGROUND:
When heart failure and tachycardia occur simultaneously, a useful diagnostic tool for early discrimination of patients with benign tachycardia-mediated cardiomyopathy (TMC) versus major structural heart disease (MSHD) is not available. Such a tool is required to prevent unnecessary and wearing diagnostics in patients with reversible TMC. Moreover, it could lead to early additional diagnostics and therapeutic approaches in patients with MSHD.
METHODS:
A total of 387 consecutive patients with supraventricular arrhythmia underwent assessment at a single center. Of these patients, 40 fulfilled the inclusion criteria with a resting heart rate ≥100 bpm and an impaired left ventricular ejection fraction <40%. In all patients, successful electrical cardioversion was performed. At baseline, day 1 and weekly for 4 weeks, levels of NT-proBNP and echocardiographic parameters were evaluated. An NT-proBNP ratio (BNP-R) was calculated as a quotient of baseline NT-proBNP/follow-up NT-proBNP. After 4 weeks, cardiac catheterization was performed to identify patients with a final diagnosis of TMC versus MSHD.
RESULTS:
Initial NT-proBNP concentrations were elevated and consecutively decreased after cardioversion in all patients. Multivariate regression and ROC analysis revealed that BNP-R discriminated between patients with TMC versus MSHD independent and superior to all other variables. The area under the ROC curve for BNP-R to detect TMC was 0.90 (95% CI 0.79-1.00; p < 0.001) after 1 week and 0.995 (95% CI 0.99-1.00; p < 0.0001) after 4 weeks. One week after cardioversion already, a BNP-R cutoff ≥2.3 was useful for TMC diagnosis indicated by an accuracy of 90%, sensitivity of 84% and specificity of 95%.
CONCLUSION:
BNP-R was found to be highly accurate for the early diagnosis of TMC.
AuthorsAmir M Nia, Natig Gassanov, Kristina M Dahlem, Evren Caglayan, Martin Hellmich, Erland Erdmann, Fikret Er
JournalClinical research in cardiology : official journal of the German Cardiac Society (Clin Res Cardiol) Vol. 100 Issue 10 Pg. 887-96 (Oct 2011) ISSN: 1861-0692 [Electronic] Germany
PMID21538234 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Biomarkers
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
Topics
  • Aged
  • Biomarkers (blood)
  • Cardiac Catheterization
  • Cardiomyopathies (blood, diagnosis, etiology, physiopathology, therapy)
  • Early Diagnosis
  • Echocardiography, Doppler
  • Electric Countershock
  • Exercise Test
  • Female
  • Germany
  • Heart Failure (blood, diagnosis, etiology, physiopathology, therapy)
  • Heart Rate
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain (blood)
  • Peptide Fragments (blood)
  • Pilot Projects
  • Predictive Value of Tests
  • ROC Curve
  • Recovery of Function
  • Stroke Volume
  • Tachycardia, Supraventricular (blood, complications, diagnosis, physiopathology, therapy)
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: